
Need professional-grade analysis? Visit stockanalysis.com
$56.34B
16.00
12,716
2.13%
Price Chart
Risk-Adjusted Performance
Also Listed On
Aflac Incorporated (AFL) Price Performance
Aflac Incorporated (AFL) trades on United States in USD. The company is classified in the Financial Services sector under the Insurance - Life industry. The stock currently trades at $106.22, down 1.58% from the previous close.
Over the past year, AFL has traded between a low of $97.05 and a high of $117.47. The stock has lost 1.6% over this period. It is currently 9.6% below its 52-week high.
Aflac Incorporated has a market capitalization of $56.34B, with a price-to-earnings ratio of 16.00 and a dividend yield of 2.13%.
About Aflac Incorporated
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Company Info
- Sector
- Financial Services
- Industry
- Insurance - Life
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $17.16B
- EBITDA
- $4.79B
- Profit Margin
- 21.24%
- EPS (TTM)
- 6.82
- Book Value
- 56.85
Technical Indicators
- 52 Week High
- $119.32
- 52 Week Low
- $95.64
- 50 Day MA
- $111.57
- 200 Day MA
- $108.07
- Beta
- 0.65
Valuation
- Trailing P/E
- 16.00
- Forward P/E
- 14.43
- Price/Sales
- 3.28
- Price/Book
- 1.90
- Enterprise Value
- $62.29B